The proposed approach of blockchain use for decentralized storage of personal medical data will improve client data
safety and security, and help to merge disparate databases, making the interaction between clients, doctors, medical
institutions, insurance and pharmacological companies more transparent and efficient. Impersonal customer data will
be ""portable"" through decentralized storage within the BioGenom 2.0 ecosystem, and all data processing operations
will be under client control. Data ownership is provided by a IPFS hash private key, which is written into the
blockchain. For the interaction of all health care market participants, a smart contract is used that provides the
automatic fulfillment of commercial transaction conditions.
The main platform objectives are:
- To regulate and protect informal medical data market;
- To simplify the procedure of valid medical data searching;
- To provide an opportunity of transaction processing eliminating middlemen.
We plan to implement the blockchain into BioGenom ecosystem in 2020 so at present time we are in the preparatory phase.
I am blockchain newcomer but my team is highly experienced.
The BioGenom 2.0 platform seeks to completely decentralize the trade and web-services market in the field of biomedicine based on modern IT-technologies integration.
We plan to attract customers to use our medical platform and applied products:
All BioGenom activities are aimed at healthy longevity provision that is one of the greatest demands of the modern society.